Muscarinic receptor heterogeneity in guinea pig intestinal smooth muscle: binding studies with AF-DX 116.

PubWeight™: 1.01‹?› | Rank: Top 15%

🔗 View Article (PMID 3666041)

Published in Eur J Pharmacol on September 23, 1987

Authors

E Giraldo1, E Monferini, H Ladinsky, R Hammer

Author Affiliations

1: Department of Biochemistry, Istituto De Angeli, Milan, Italy.

Articles by these authors

Pirenzepine distinguishes between different subclasses of muscarinic receptors. Nature (1980) 5.39

Muscarinic receptor subtypes: M1 and M2 biochemical and functional characterization. Life Sci (1982) 3.02

Binding profile of a novel cardioselective muscarine receptor antagonist, AF-DX 116, to membranes of peripheral tissues and brain in the rat. Life Sci (1986) 1.79

Atropine poisoning in children during the Persian Gulf crisis. A national survey in Israel. JAMA (1992) 1.62

Tiotropium (Spiriva): mechanistical considerations and clinical profile in obstructive lung disease. Life Sci (1999) 1.58

RAB-plate vs Richards CHS plate for unstable trochanteric hip fractures. A randomized study of 233 patients with 1-year follow-up. Acta Orthop Scand (1998) 1.41

Macrophages of the mammalian small intestine: a review. J Reticuloendothel Soc (1979) 1.38

A quantitative study of the anticholinergic action of several tricyclic antidepressants on the rat isolated fundal strip. Br J Pharmacol (1972) 1.36

Novel developmental specificity in the nervous system of transgenic animals expressing growth hormone fusion genes. Nature (1985) 1.31

Studies on the in vitro interaction of electrical stimulation and Ca++ movement in sarcoplasmic reticulum. J Gen Physiol (1966) 1.28

Ba 679 BR, a novel long-acting anticholinergic bronchodilator. Life Sci (1993) 1.22

Pathogenesis of rotaviral enteritis in gnotobiotic pigs: a microscopic study. Am J Vet Res (1980) 1.11

Characterization of the muscarinic receptor subtypes in the rat urinary bladder. Eur J Pharmacol (1988) 1.10

Characterization of muscarinic receptors in guinea pig ileum longitudinal smooth muscle. Mol Pharmacol (1988) 1.08

Characterization of a novel 5-HT4 receptor antagonist of the azabicycloalkyl benzimidazolone class: DAU 6285. Naunyn Schmiedebergs Arch Pharmacol (1992) 1.08

Increase in striatal acetylcholine levels in vivo by piribedil a new dopamine receptor stimulant. Life Sci (1974) 1.06

Binding and functional characterization of the cardioselective muscarinic antagonist methoctramine. J Pharmacol Exp Ther (1988) 1.03

Novel potent inhibitor of receptor-activated nonselective cation currents in HL-60 cells. Mol Pharmacol (1993) 0.99

Azabicycloalkyl benzimidazolone derivatives as a novel class of potent agonists at the 5-HT4 receptor positively coupled to adenylate cyclase in brain. Naunyn Schmiedebergs Arch Pharmacol (1991) 0.99

Binding and functional profiles of the selective M1 muscarinic receptor antagonists trihexyphenidyl and dicyclomine. Br J Pharmacol (1986) 0.98

Distribution of muscarinic receptor subtypes in rat brain as determined in binding studies with AF-DX 116 and pirenzepine. Life Sci (1987) 0.96

Misonidazole combined with split-course radiotherapy in the treatment of invasive carcinoma of larynx and pharynx: report from the DAHANCA 2 study. Int J Radiat Oncol Biol Phys (1989) 0.96

5-HT4 receptor stimulation facilitates acetylcholine release in rat frontal cortex. Neuroreport (1994) 0.96

Subclasses of muscarinic receptors and pirenzepine. Further experimental evidence. Scand J Gastroenterol Suppl (1982) 0.94

Muscarinic receptors in the stomach. Scand J Gastroenterol Suppl (1980) 0.94

Role of the hippocampus in the sex-dependent regulation of eating behavior: studies with kainic acid. Physiol Behav (1986) 0.94

Spontaneous rupture of the liver. A complication of oral anticoagulant therapy. Arch Surg (1979) 0.92

Specific receptors for sulfonylureas in brain and in a beta-cell tumor of the rat. Biochem Pharmacol (1982) 0.89

Muscarinic receptor heterogeneity in smooth muscle: binding and functional studies with AF-DX 116. Trends Pharmacol Sci (1988) 0.88

Characterization of muscarinic receptor subtypes in human tissues. Life Sci (1988) 0.87

Mammalian glial cells in culture synthesize acetylcholine. Naunyn Schmiedebergs Arch Pharmacol (1997) 0.87

Serotonergic facilitation of acetylcholine release in vivo from rat dorsal hippocampus via serotonin 5-HT3 receptors. J Neurochem (1994) 0.87

Comparative anatomical distribution of serotonin 1A, 1D alpha and 2A receptor mRNAs in human brain postmortem. Brain Res Mol Brain Res (1996) 0.86

Storage and release of acetylcholine in the isolated superior cervical ganglion of the rat. Brain Res (1978) 0.86

Use of delayed pushing with epidural anesthesia: findings from a randomized, controlled trial. J Perinatol (1999) 0.86

Impact of maternal obesity and maternal overweight on the detection rate of fetal heart defects and the image quality of prenatal echocardiography. Ultraschall Med (2011) 0.85

Inhibition of gastric acid secretion by pirenzepine (LS 519) in man. Scand J Gastroenterol (1979) 0.85

The stability of union in tibial shaft fractures: its measurement by a non-invasive method. Arch Orthop Trauma Surg (1984) 0.85

Identification of serotonin 5-HT4 recognition sites in the porcine caudate nucleus by radioligand binding. Neuropharmacology (1994) 0.85

Binding of an imidazolidine (clonidine), an oxazoloazepin (B-HT 933) and a thiazoloazepin (B-HT 920) to rat brain alpha-adrenoceptors and relation to cardiovascular effects. Eur J Pharmacol (1980) 0.84

Arteriovenous malformation of the uterus associated with a missed abortion. Ultrasound Obstet Gynecol (1994) 0.84

Ctla4 and multiple sclerosis in the Italian population. Exp Mol Pathol (2005) 0.84

Selective labelling of M1-receptors in autonomic ganglia with 3H-pirenzepine. Arzneimittelforschung (1985) 0.83

Spontaneous subcapital femoral neck fracture after healed trochanteric fracture. Clin Orthop Relat Res (1997) 0.83

An international pharmacokinetic study on pirenzepine following a single oral dose. Scand J Gastroenterol Suppl (1980) 0.83

Determination of endogenous acetylcholine release in freely moving rats by transstriatal dialysis coupled to a radioenzymatic assay: effect of drugs. J Neurochem (1987) 0.83

Transgenic mice expressing a human apolipoprotein[a] allele. J Lipid Res (1999) 0.83

Acetylcholine, choline and choline acetyltransferase activity in the developing brain of normal and hypothyroid rats. J Neurochem (1972) 0.83

BIMG 80, a novel potential antipsychotic drug: evidence for multireceptor actions and preferential release of dopamine in prefrontal cortex. J Neurochem (1997) 0.82

RAB-plate versus sliding hip screw for unstable trochanteric hip fractures: stability of the fixation and modes of failure--radiographic analysis of 218 fractures. J Trauma (2001) 0.82

Muscarinic receptor subclasses: evidence from binding studies. Adv Biochem Psychopharmacol (1983) 0.82

Improved external skeletal fixation for unstable fractures. Clin Orthop Relat Res (1987) 0.82

Decreased Ca2+ uptake by sarcoplasmic reticulum after coronary artery occlusion for 60 and 90 minutes. Circ Res (1967) 0.81

Therapeutic potential of CNS-active M2 antagonists: novel structures and pharmacology. Life Sci (1993) 0.81

Regulation of plasma aldosterone levels by metoclopramide: a reappraisal of its mechanism from dopaminergic antagonism to serotonergic agonism. Neuropharmacology (1997) 0.81

Effect of chemical sympathectomy on the content of acetylcholine, choline and choline acetyltransferase activity in the cat spleen and iris. J Physiol (1972) 0.81

Compensation of muscarinic bronchial effects of talsaclidine by concomitant sympathetic activation in guinea pigs. Eur J Pharmacol (1997) 0.81

Benzimidazolones and renzapride facilitate acetylcholine release from guinea-pig myenteric plexus via 5-HT4 receptors. Naunyn Schmiedebergs Arch Pharmacol (1995) 0.81

Evaluation of fracture stability. A mechanical simulator for assessment of clinical judgement. Acta Orthop Scand (1984) 0.81

The pharmacokinetic profile of pirenzepine. Scand J Gastroenterol Suppl (1979) 0.80

BIMT 17, a 5-HT2A receptor antagonist and 5-HT1A receptor full agonist in rat cerebral cortex. Naunyn Schmiedebergs Arch Pharmacol (1995) 0.80

Gastroprokinetic properties of the benzimidazolone derivative BIMU 1, an agonist at 5-hydroxytryptamine4 and antagonist at 5-hydroxytryptamine3 receptors. Naunyn Schmiedebergs Arch Pharmacol (1994) 0.80

Pharmacokinetics of mifentidine after single and multiple oral administration to healthy volunteers. Br J Clin Pharmacol (1988) 0.80

Tricyclic compounds as selective muscarinic receptor antagonists. 3. Structure-selectivity relationships in a series of cardioselective (M2) antimuscarinics. J Med Chem (1989) 0.80

Cimetropium: characterization of antimuscarinic and spasmolytic properties. Arzneimittelforschung (1985) 0.79

Attempted unreamed nailing in tibial fractures: a prospective consecutive series of 55 patients. Acta Orthop Scand (1998) 0.79

Long-term effects of haloperidol, Clozapine, and methadone on rat striatal cholinergic and dopaminergic dynamics. Adv Biochem Psychopharmacol (1980) 0.79

Acute infection with parvovirus B19 in early pregnancy. Ultrasound Obstet Gynecol (2009) 0.79

Endogenous serotonin facilitates in vivo acetylcholine release in rat frontal cortex through 5-HT 1B receptors. J Pharmacol Exp Ther (1996) 0.79

The orphan receptor cDNA RDC4 encodes a 5-HT1D serotonin receptor. Biochem Biophys Res Commun (1991) 0.79

Neurochemical effects of buspirone, a novel psychotropic drug, on the central cholinergic system. J Pharm Pharmacol (1982) 0.79

Localization and gene expression of serotonin 1A (5HT1A) receptors in human brain postmortem. Brain Res (1994) 0.79

Differences between rat dorsal and ventral hippocampus in muscarinic receptor agonist binding and interaction with phospholipase C. Eur J Pharmacol (1993) 0.78

Ultrastructure of macrophages of the murine Peyer's patch dome. Exp Cell Biol (1983) 0.78

[Ambroxol, studies of biotransformation in man and determination in biological samples (author's transl)]. Arzneimittelforschung (1978) 0.78

Factor from rat small intestine potently affects opiate receptor binding. Life Sci (1981) 0.78

Ex vivo binding of flibanserin to serotonin 5-HT1A and 5-HT2A receptors. Pharmacol Res (2001) 0.78

Effect of central stimulants and depressants on mouse brain acetylcholine and choline levels. Eur J Pharmacol (1972) 0.78

High-quality genomic DNA from human whole blood and mononuclear cells. Biotechniques (2002) 0.78

Characterization of muscarinic receptors in salivary and lacrimal glands of the rat. Eur J Pharmacol (1987) 0.78

Identification of a novel polymorphism in the fibronectin type II domain of the SEL1L gene and possible relation to the persistent hyperinsulinemic hypoglycemia of infancy. Mutat Res (2004) 0.78

Comparison of the effects of the stereoisomers of fenfluramine on the acetylcholine content of rat striatum, hippocampus and nucleus accumbens. J Pharm Pharmacol (1980) 0.78

Tricyclic compounds as selective antimuscarinics. 2. Structure-activity relationships of M1-selective antimuscarinics related to pirenzepine. J Med Chem (1988) 0.78

Further characterisation of [3H]8-hydroxy-2-(di-N-propylamino)tetralin binding sites in human brain postmortem. Neurochem Int (1997) 0.78

Pharmacodynamic profile of the M1 agonist talsaclidine in animals and man. Life Sci (2001) 0.77

Inhibition of human leukocyte metabolism and random mobility by local anaesthesia. Acta Anaesthesiol Scand (1985) 0.77

Mode of action of gamma-butyrolactone on the central cholinergic system. Naunyn Schmiedebergs Arch Pharmacol (1983) 0.77

Evidence of an interaction between serotoninergic and cholinergic neurons in the corpus striatum and hippocampus of the rat brain. Brain Res (1978) 0.77